In addition to the aforementioned studies, which have been verified through in vitro experiments, there are reports based on RNA sequencing data analysis indicating a potential correlation between abnormal NFE2L3 expression and the prognosis of various cancers, such as lung adenocarcinoma (Ren J. et al., 2020), malignant pleural mesothelioma (Wang et al., 2022), ovarian cancer (Dou et al., 2022), glioblastoma multiforme (Rowther et al., 2016), and laryngeal carcinoma (Xue et al., 2020). Here, NFE2L3 is linked to glioblastoma.